chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 09/1/2021, I woke up with extreme dizziness and the room was spinning.  I could not get out of bed. I was feeling nauseas and feeling dehydrated.   I stayed mostly in bed for most of the day.   It did not get better. On 9/14/2021, I went to see the doctor.  I got a hearing test and  other tests.  The right ear did show some abnormality and may showed a viral infection in the inner ear.   I also saw my PCP who prescribed Meclizine pills  and Azelastine nasal spray.  The medication did help with resolving the nausea.   I was diagnosed with vestibular neuritits. I have a follow up appt this week.   I also noticed increased arthritis pain in hips, knees, and left thumb.
This spontaneous report as received from a nurse refers to a female patient of unknown age. On 15-MAY-2013 the patient was vaccinated with GARDASIL dose 3, intramuscular. It was reported that on an unknown date the second dose of GARDASIL was administered to he in her buttocks at another provider's office. Dosing information was not provided. No adverse effects were reported. Additional information has been requested.
nose clogged due to allergies; Chest pain; Nose bleed; Headache; This is a spontaneous report from a contactable consumer or other non hcp (parent). A 14-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0170), via an unspecified route of administration, administered in Arm Right on 17May2021 15:00 (at the age of 14-years-old) as dose 1, single for covid-19 immunisation. Medical history included ongoing hypersensitivity (Verbatim: Allergies). The patient's concomitant medications were not reported. Prior Vaccinations reported as none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as none. Patient mother stated that her son got the Pfizer Covid vaccine this past Monday on 17May2021 15:00, and yesterday on 18May2021 he had a headache and nose bleed, patient mother thinks that he got too hot. This morning on 19May2021 he had chest pain. On an unspecified date he also had nose clogged due to allergies. Patient mother stated that she had not contacted the physician yet, they are not open yet this morning. Patient received treatment with claritin as a result of events. The patient did not require emergency room. Outcome of the events headache and nose bleed was recovered on 18May2021. Outcome of the events chest pain and nose clogged due to allergies was not recovered.  No follow-up attempts possible. No further information expected.
On 10/14/15 the patient acute unprovoked sharp low back pain. Back pain got progressively worse and began to radiate to lower extremities. By 10/28/15 sx of pain numbness and weakness was experienced in both legs and arms. Pt also reports difficulty walking, metallic taste.
Pt recvd 2nd dose of vax & exp burning, nausea, & dizziness; pt still nauseous & dizzy;
Initial information received on 10-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 39 years old female patient who experienced a severe allergic reaction, while she received vaccine FLUZONE. The patient's past vaccination(s) included FLUARIX with no reactions and never got the flu and everything was fine. The patient's past medical history, concomitant medication and family history were not provided. Notes: Patient has no egg allergy and states that before that she had the flu vaccine for 8 years in a row with no problem. On 30-Nov-2016, the patient received a 0.5ml dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED lot 41673AB, expiry date 30-Jun-2017 via unknown route in unknown site. On an unknown date, the patient developed a non-serious a severe allergic reaction with unknown latency following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED. On an unknown date, the patient developed a non-serious hives with unknown latency following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED. On an unknown date, the patient developed a non-serious scratchy throat with unknown latency following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED. On an unknown date, the patient developed a non-serious triggered asthma attack with unknown latency following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED. The patient had a ER visit to doctor. Lab data was not provided. Final diagnosis was a severe allergic reaction. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for a severe allergic reaction, as Unknown for hives, as Unknown for scratchy throat and as Unknown for triggered asthma attack. List of documents held by sender- none.
Shaking, fever, Chills, pain in hands and back, severe stomach pains with dry heaves, unable to sleep, heart pounding
rash on her back and stomach; This is a spontaneous report from a contactable consumer (patient herself). A 77-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was unknown), via an unspecified route of administration on 16Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. On 04Mar2021, the patient experienced rash on her back and stomach. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt has large, hot, red lump on L arm where vx was administered SQ.
Information has been received from a health professional concerning an 11 year old male, with no medical history and no allergies, who on 15-Dec-1995 was vaccinated with a dose of varicella virus vaccine live (Lot #610248/0446B). There was no concomitant medication. On 17-Mar-2006 the patient developed fatigue and an itchy red raised rash. The patient was examined in a physician's office on 20-Mar-2006. The patient was started with amoxicillin and calamine lotion, and a throat culture was collected. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No product quality complain was involved. The reporter felt that the patient's reaction was an other import medical event (OMIC). Additional information has been requested.
For first shot five days of fatigue and chills starting immediately with injection.  For second shot starting third day after injection two weeks of fatigue, chills, non stop runny nose and BP constantly at 140/100 - no fever, followed by two weeks of starting to feel better but having relapses, followed by one month of chronic fatigue, followed by four months of long haul fatigue with the fourth month being the worst month of fatigue. Fatigue caused me to frequently need naps up to an hour. No symptoms since first week of October 2021.
mom reports that pt had small red dots all over body-not heavy coverage seen 4hrs p/vax;parent called MD & was told to bring pt in if rash still present in 24hrs;rash was gone next AM;parent was told pt may need reduced dose next vax
THE PATIENT REPORTED HAVING ADVERSE EFFECTS AFTER RECEIVING A FLUAD VACCINE. SHE COMPLAINED OF MUSCLE SWELLING AT AND AROUND THE SITE OF THE VACCINE ADMINISTRATION. SHE ALSO REPORTD THAT THERE WAS BRUISING AND SOME PAIN AROUND THE VACCINE ADMINISTRATION SITE.  I INSTRUCTED HER TO ICE THE SWELLING AND TAKE A PAIN RELIEVER IF NECESSARY OVER THE NEXT 2 TO 3 DAYS. I ALSO TOLD HER IF IT NOT GETTING BETTER OR YOU ARE VERY UNCOMFORTABLE TO CALL HER DOCTOR AS WELL AS THE PHARMACY AGAIN.
it was rpt fr NP concerning pt who was vax. approx 1yr later pt sibling was vax & subsequent to the siblings vax the pt devel chickenpox
Severe stomach pain/cramps 7/10, Nausea, general malaise, headache, weakness
23 old male who received FLU MIST 21Sep09. He was seen in ED on 8Oct09 for 1 day h/o fever f/b HA, N/V, treated conservatively and discharged home. Sxs continued intermittently, and he was seen ED 2 more times, then visited to local hospital on 15Oct09 with LE weakness, then became respiratory failure requiring intubation. In ICU on vent. Unable to move lower extremities, able to flex both arms and responsive. Foley cath. Received TPN -->tube feedings. Temp peaked at 102.2 on admission. IV antiviral administered. IVIG started on 19 Oct; dc'd on 22 Oct. 10/08/09, ER note: T 99.9. C/o fever since yesterday. Today felt nauseous and vomited several times. No abd pain. Frontal h/a (10/10). No meningimus. (+) rhinorrhea. Tx'd MOTRIN and received 3L IVFs with almost complete resolution of h/a. 10/9/09, ER: T 98.9, c/o fever, N/V, h/a, abd discomfort for 2 days. Shivering. No neck stiffness. Received IVFs, PHENERGAN, ZANTAC, REGLAN and TYLENOL and prescribed PHENERGAN and MOTRIN. Dx: Viral syndrome. Felt much improved upon discharge. 10/13/09, ER: T 99.9, c/o vomiting x 10 overnight, epigastric pain, h/a and congestion. Int Med Consulted for endoscopy. 24 Oct, sputum MRSA positive. 25 Oct, bloody urine --> CT kidney, r/o thrombo-embolism. 26 Oct, chest CT and angiogram done to r/o PE. 29 Oct, good movement of UE, communicates by writing, able to move toes. Referral to Nephrologist (+ proteinuria). 2 Nov, some movement of ankles. Nephrology consult - normal. 4 Nov, started SOLUMEDROL 1 gm IV. 5 Nov, 2nd dose of SOLUMEDROL, planning trach. 6 Nov, no change in motor level (ankles). Symptoms: Chills, Fever, Headache, general, Nausea w/ vomiting, Weakness, Dyspnea (shortness of breath).
4/14/2021 - Within a half hour of the shot, he could barely lift his arm which we know is a normal part of the vaccine.  As the night went on, it gradually worsened and he was unable to use his arm to complete his job as a custodian.  The next morning he was unable to move his up up and down and complained that they may have given him the shot in the wrong place of his muscle.  After comparing where the shot should have been we determined it was probably just part of the process and he continued to take Motrin and Tylenol.   4/22/2021 - After more than a week he is still unable to raise his arm half way as from his muscle to the top of his shoulder is pain.  We contacted our family physician who indicated she had not heard of the pain from the shot lingering for more than a few days.   She advised him for the next 48 to take 1000 MG of Tylenol and 800 MG of Motrin for the next 48 hours.  4/23/2021 -  We are currently following her advice however it does not seem to be helping the pain at this time.
When I lay on my left arm I get some soreness  with tingling in fingers ,,Still get very tired after activities with chills and feverish feeling.
fever; still tired; This spontaneous case was reported by an other and describes the occurrence of PYREXIA (fever) and FATIGUE (still tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and FATIGUE (still tired). At the time of the report, PYREXIA (fever) had resolved and FATIGUE (still tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Reactivated head herpes, but this time in the eyelid. Red eye, swollen lids, pus pockets. Treated with doctors repeatedly. Treated from 11/13/2012 and still 12/12/2012.
April 8, 2019- gets a normal cold but body is unable to fight it and gets sicker than we have ever seen her; appears "defenseless."  Lasts for a week. April 16, 2019- gets severe flu symptoms with high fever and non-stop throwing up.  Immune system seems severely compromised. Lost 5-7 pounds and sick for a week. Thin and week for weeks after. May 16, 2019- in the evening, out of character panic and fit of crying along with a "desperate" need for food and water. Never observed this behavior in her, even as a young child. June 1, 2019- VERY sick again with extremely high fever (105-106). Severe chest cough. Never experienced either this level of fever or this severe a chest cough. Immune system seems very compromised. She is exhausted, loses weight again and remains week even after symptoms resolve more than a week later.  June 12, 2019- receive treatment plan to strengthen immune system. Hasn't been sick since. Still on that treatment plan now. (When she was little and got her Dtaps in a row, she developed a chronic cough that lasted for 6 months until we got a proper diagnosis and treatment).
pt recvd vax 25JAN93 & w/in 24 hrs devel inject site reaction of erythema, swelling & tenderness approx the size of a silver dollar; seen by MD 27JAN93; treated w/ATB for poss early cellulitis;
Fever developed 12/7/12 without other symptoms except irritability. Fever x 2 days resolved. URI sx developed 12/10/12 and generalized rash 12/12/12.
After 1-2 minutes of administering vaccine pt started sweating profusely and was light headed.  Advised pt to sit, breathing seemed fine.  Had manager call 9-1-1.  Pt lost color of skin.  Tried checking BP with arm cuff machine, but didn't work.  Had EpiPen on standby while friend call pt parents.  Gave bottle of water to pt while talking and observing.  EMS arrived and checked BP-normal.  Pt left on own accord after resting for 30 minutes.
Hives on face and neck worsening to stridorous breath sounds.; Hives on face and neck worsening to stridorous breath sounds.; This is a spontaneous report from a contactable nurse. A 47-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration in left arm on 21Jan2021 10:15 at a single dose for COVID-19 immunization. Vaccination was done in a hospital. Medical history included asthma, ulcerative colitis, sub clinical Hashimotos, and known allergies to eggs and dairy.  Concomitant medication included mesalamine (MESALAMINE), levocetirizine dihydrochloride (XYZAL), budesonide, formoterol fumarate (SYMBICORT), procaterol hydrochloride (PRO-AIR), and montelukast sodium (SINGULAIR).  The patient previously received the first dose of bnt162b2 on 31Dec2020 09:30 in left arm(lot number: EL0142) for COVID-19 immunization. The patient experienced hives on face and neck worsening to stridorous breath sounds on 22Jan2021 12:00. The outcome of the events was recovering.  The event resulted in an emergency room/department or urgent care.  Treatment included Epinephrine, Benadryl, Prednisone. The patient did not have CVOID-prior to vaccination and was not tested for COVID-19 post vaccination.; Sender's Comments: Based on currently known drug safety profile, a causal association between the reported events hives on face and neck worsening to stridorous breath sounds and bnt162b2 cannot be excluded. The patient's underlying risk factors/predisposing condition asthma is considered as a risk factor to develop the event stridorous breath sounds.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and investigators, as appropriate.
pt arrives via EMS, pt c/o generalized weakness and not eating for several days. missed dialysis
COULD NOT MOVE; CHILLS; HEADACHES- PIERCING ON THE RIGHT SIDE; NOT GOOD; TIRED; NAUSEAS; SHORTNESS OF BREATH; MOUTH WATERING; CHEEKS SORE; BODY ACHES; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, and other pre-existing medical conditions included brio in am from 2015 due to overuse of pesticide at work. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included salbutamol for asthma.  On MAR-2021, treatment medications included: ibuprofen. On 22-MAR-2021, the subject experienced shortness of breath. On 22-MAR-2021, the subject experienced mouth watering. On 22-MAR-2021, the subject experienced cheeks sore. On 22-MAR-2021, the subject experienced body aches. On 22-MAR-2021, the subject experienced not good. On 22-MAR-2021, the subject experienced tired. On 22-MAR-2021, the subject experienced nauseas. On 23-MAR-2021, the subject experienced could not move. On 23-MAR-2021, the subject experienced chills. On 23-MAR-2021, the subject experienced headaches- piercing on the right side. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not move, and chills on 25-MAR-2021, shortness of breath, mouth watering, cheeks sore, not good, tired, nauseas, and headaches- piercing on the right side, and body aches on 05-APR-2021. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.
experiencing large blood clots during menstruation, this has never happened prior to being vaccinated difficulty conceiving
Received Pfizer as 1st dose and Moderna as 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st dose and Moderna as 2nd dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F2N) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 12-Aug-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st dose and Moderna as 2nd dose). On 02-Sep-2021, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer as 1st dose and Moderna as 2nd dose) had resolved.            No concomitant medications were provided.
Information has been received from a female patient who on 16-JUL-2007 was vaccinated with a dose of Zostavax (Oka/Merck). It was reported that on 17-JUL-2007 night the patient had an itchy bump on her left shoulder. On 18-JUL-2007 night, the patient developed shingles on left shoulder and left breast. The patient described it as "quite unsightly" and a painful itching mess. On 19-JUL-2007 the patient saw the physician.
I woke up 7 days after vaccine with a red, raised, rash on my left arm appx 4" x 2"
red blotches on some parts of the body/ looks like a sunburn; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red blotches on some parts of the body/ looks like a sunburn) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-May-2021, the patient experienced RASH MACULAR (red blotches on some parts of the body/ looks like a sunburn). At the time of the report, RASH MACULAR (red blotches on some parts of the body/ looks like a sunburn) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment information was not provided   Reporter did not allow further contact
This patient was admitted to Hospital on 1/10/2022 for COVID pneumonia. This is considered a breakthrough case.
Death 6/6/2021 Causes of death listed on death certificate: 1) covid pneumonia
Received Flu Vaccine on 10/28/14. Afterwards experienced significant shoulder pain which continues to hurt and affect her mobility of whole arm and has not improved.
Expired Vaccine(Exp: 04/28/2021) was administered on 04/29/2021.
< 50 lesions-Atavax 1 tsp QID and A  cyclovine 2tsp QID x 7 days.
Flu like symptoms. Muscle aches, nausea, abdominal pain, severe headache, severe chills, fever
Fever, shortness off breath, heart palpitations, significant pain at the injection site.  Effects lasted 36-48 hours and were evident after both vaccinations.  I am retired military and have received many shots most people will never receive, including the full Anthrax series and Plague, but I have never had this kind of a reaction from any vaccine.
Initial exam showed bloody stools, intussusception. DC DX: Intussusception. Procedure: exp. lap. with reduction of intussuception and right hemicolectomy. Taken emergently to operating room after water-soluble contrast enema was unable to reduce intussusception. Currant jelly stools starting at 8am on 9/17/06. Mass palpable at the midline of her abdomen.  Hospital course uneventful, developed rash thought to be due to Unasyn, changed to Clindamycin. Surgical pathology report: sections show extensive ischemic necrosis secondary to intussusception. Appendiceal nucosa also shows ischemic necrosis. The amount of lymphoid tissue appears to be increased. Resected margins contain viable tissue.
Patient presented to ED on 7/15/2022 woke up sweaty, weak, tremors in upper extremities and increased shortness of breath. NSTEMI.
Decedent was given Paxlovid on 08/08/2022 after being diagnosed with COVID19
This spontaneous case, initially received from a pharmacist on 24-Sep-2018, concerning a 74-year-old, elderly patient of an unspecified gender. The patient's medical history and concomitant medications were not available. Since 03-Sep-2018, the refrigerator's temperature fluctuated above 47F and FLUAD (TIV) vaccine exposed to temperatures in the range of 47F to 50.9F (explicitly coded as incorrect product storage). On 12-Sep-2018, the patient was administered FLUAD TIV [dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number and expiry date: not reported] which underwent temperature excursion (explicitly coded as drug administration error). The patient did not experience any adverse drug reaction after the vaccination. The reporter assessed the case as non-serious. This case 201804095 cross-linked to original case 201804076 due to the same reporter. Non-significant follow-up received from the reporter on 14-Nov-2018: Info number (SEQ18-04086) was updated in the additional information tab. No changes were made in the narrative.
10min p/vax became pale went to knees, was unable to communicate this lasted 10mins-stated was aware the entire time c/o twitching w/rigidity on rt side; seen in ER & since that time dx w/sz & placed on dilantin, tegretol w/medrol;
My arm was sore and I felt tired.  I also had a very low grade fever.  This lasted for several hours
When I received the vaccine, about two minutes later, I began to feel a warmness in my arm and left hand. The feeling of warmth spread across the left shoulder, left side of the neck, left side of the face, left eye, left lip and left side of the head. I felt a tingling sensation all over that area. I started pain on the left side of my head. The feeling of heaviness and discomfort in the head lasted three days. I was so worried it was a stroke.
Patient had used topical Neosporin 2 + times per year for many years for minor skin abrasions etc.  Patient received ZOSTAVAX 9/07 and 1 month later still had an indurated SQ area with mild erythema at injection site.  He used Neosporin about 3 months later and had prolonged erythema and pruritus on his opposite forearm.  Patch testing proved allergy to Neomycin.  This seems suspicious that ZOSTAVAX induced new neomycin allergy.